Standardized PSADT calculations are crucial for timely prostate cancer treatment, potentially preventing metastasis and reducing treatment costs. Casdatifan shows promise in clear cell RCC, with a 100 ...
The objectives of this article are to describe updates to the ASCO Global Guidelines methods and to provide background of the motivations for Global Guidelines that are responsive to varying access to ...
Phase 1 and 3 trials demonstrated improved survival rates, with new treatment strategies for EGFR-mutated NSCLC, HER2+ breast cancer, and small-cell lung cancer. AI innovations, such as the ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results